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Abstract Large cell calcifying sertoli cell tumor
(LCCSCT) is an exceptionally rare neoplasm originat-
ing from sperm cord cells. The tumors have relatively
low malignant potential and unlikely proceed to metas-
tasis formation. The lesions may occur in an isolated
form or in ca. 40% of cases may be associated with
genetic abnormalities, by and large Peutz–Jeghers
syndrome and Carney complex. At presentation, 20%
of LCCSCT cases are bilateral and/or multifocal.
Owning to characteristic skin lesions and particular
hyperechoic ultrasound image of the tumor, preliminary
diagnosis of the syndromic LCCSCT is possible in the
preoperative period. Consequently, testicle organ–spar-
ing procedure can be attempted, which is especially
justified in bilateral lesions. Here, we report a case of a
bilateral LCCSCT in a 20-year-old man with atypical
Peutz–Jeghers syndrome due to amplification of the
exon 1 of STK11 gene who was successfully treated
with bilateral testicle-sparing tumorectomies.
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Introduction
Due to its generally malignant behavior, radical
inguinal orchidectomy is the ‘‘gold standard’’ for the
treatment of a testicular tumor. Nevertheless, in some
less frequent histological subtypes of tumors with low
malignant potential organ-sparing approach: partial
orchidectomy or even testicle-sparing excisions of
tumors could be attempted [1]. Since there are no
reliable non-invasive diagnostic tests available which
would allow unequivocal differential diagnosis of the
lesion in the preoperative period, it is recommended
that the testicle should be first exposed and frozen
section biopsy should be performed prior to main
surgery [2].
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Large cell calcifying sertoli cell tumor (LCCSCT)
is a very uncommon sex cord stromal neoplasm.
Usually, the disease presents in adolescents and young
adults with slowly enlarging painless testicular mass or
gynecomastia [3]. In up to 40% of cases, it coinci-
dences with inherited genetic syndromes such as
Peutz–Jeghers syndrome (PJS, MIM#175200) or
Carney complex (MIM#160980) [4]. These autosomal
dominant multiple neoplasia syndromes present with a
variety of pigmented lesions of the skin and mucosae
and a number of tumors affecting many organs. Yet
still, only a small fraction of syndromic patients
develop LCCSCT—in total, about 30 cases of testic-
ular lesions have been previously reported in the
English language literature in this subgroup of patients
(reviewed by Ulbright et al. [3]). The tumors possess
low malignant potential and rarely give distant
metastases. Therefore, instead of standard radical
orchidectomy, in case of LCCSCT suspicion partial
orchidectomy is recommended.
Here, we report a case of bilateral LCCSCT in a
20-year-old man with skin lesions suggestive for PJS,
which was successfully treated with bilateral testicle-
sparing tumorectomies.
Case description
A 20-year-old man was referred to the urological
department due to bilateral testicular enlargement.
On physical examination, two hard, non-tender tumors
were detected. Besides, patient presented with dis-
persed lentiginosis on the face, hands, penis and on the
buccal mucosa (Fig. 1). Testicular lesions were
noticed 2 months before. Ultrasound examination
revealed two hyperechoic 10–11 9 9 mm tumors.
Serum alpha-fetoprotein, beta-hCGH and testosterone
levels were within normal range. Abdomen and chest
CT showed no evidence of metastases or other
pathologies.
Peculiar skin lesions and hyperechoic ultrasound
image of the bilateral tumors suggested underlying
constitutional genetic abnormality and hence plausi-
bly benign character of the testicular lesions. Conse-
quently, right tumorectomy was attempted. Frozen
section intraoperative consultation was indicative of
benign testicular neoplasm, confirming organ-sparing
approach. Accordingly, left side surgery was per-
formed in the similar manner. The final histopathol-
ogical diagnosis was LCCSCT (Fig. 2).
In order to verify clinical suspicion of the Peutz-
Jaghers syndrome, genetic testing was performed.
DNA was extracted from peripheral blood leukocytes
in accordance with the standard phenol-chlorophorm
protocol. Mutational screening of the STK11 gene was
performed by direct sequencing of all exons and
adjacent intronic junctions of the gene. Large genomic
rearrangements were analyzed by multiplex ligation-
dependent probe amplification method using SALSA
MLPA P101-A2 STK11 kit (MCR Holland), as
previously described [5]. STK11 gene amplification
confined to the promoter region and exon 1 was
detected; however, due to large size of the gene
fragment in question and its high GC content, the exact
breaking points of the rearrangement were not estab-
lished. Nevertheless, since amplification of the exon 1
results in frameshift and hence premature termination
of translation, we may safely conclude that it is
a disease-causing mutation. The resulting aberrant
mRNA either will be subjected to nonsense-mediated
decay or encode a truncated, malfunctioning protein
comprising of mere 96 N-terminal amino acids instead
of 433 residues present in the wild-type STK11 protein.
Skin lesions, histopathology type of the testicular
tumors and results of genetic tests all confirmed
diagnosis of Peutz–Jeghers syndrome. The patient was
Fig. 1 Characteristic skin lesions—lentigosis on the face (a), hands (b) and penis (c)
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referred to genetic department for further manage-
ment. No colonic polyps were found on colonoscopy.
Follow-up at 6 months showed no sign of tumor
recurrence. Testosterone level remained normal as
well as sperm parameters.
Discussion
Peutz–Jeghers syndrome is a rare genetic disorder
characterized by multiple gastrointestinal (GI)
hamartomatous polyps, mucocutaneous pigmentation
and increased predisposition to various neoplasms
[6]. Typically, PJS diagnosis is made in young adults
presenting with gastrointestinal problems such as
obstruction, pain or bleeding caused by the presence
of hamartomatous polyps in the digestive tract, who in
addition to abdominal symptoms have peculiar mela-
nin hyperpigmented spots on the face, especially
around lips and nostrils, oral mucosa, genitals, anus
and sometimes on hands or feet. Even though 88% of
PJS patients have GI polyps [6], the reported patient
neither had ever manifested any symptoms of gastro-
intestinal disease, nor had polyps detected during
eventual GI work-up. Yet still, since the most common
site of PJS polyps is the small intestine that is a difficult
organ to examine by clinical or radiological means, it
cannot be excluded that in the future the patient
becomes symptomatic. The second atypical feature of
the presented case is the type of causative mutation.
Even though one-third of PJS patients is found to have
rearrangements of the STK11 gene, on the whole these
are large exonic deletions [5]. In accordance with
Human Gene Mutation Database (http://www.hgmd.org/
accessed Oct. 2011), our patient is the second case
worldwide with an exonic amplification affecting
STK11 gene, the other patient having exon 7 duplica-
tion. In view of the rarity of such mutation, no definite
conclusions with respect to genotype–phenotype cor-
relations can be drawn.
In addition to polyps and melanin spots that are the
two constant features of the syndrome, PJS patients
have increased risk of developing various tumors. The
relative risk of cancer in these individuals is 15 times
the general population risk and the cumulative cancer
risk is 76–81% by the age of 70 years [6, 7]. The most
common sites are small intestine, colon, pancreas,
stomach, lung, breast, uterus, and ovary. The occur-
rence of ovarian tumors far exceeds that of testicular
tumors in this disorder, with the estimated cumulative
risk of 6–21% in PJS women [6, 7]. Conversely,
LCCSCTs have been observed in a few PJS patients
only, nevertheless accounting for up to one-third of all
LCCSCT reported in the available literature [3, 4].
In contrast to sporadic LCCSCT cases, PJS men
develop cancer at earlier age (6.5 vs. 16 years) [3, 4].
In PJS, the first manifestation typically results from
hormonal activity of the tumor and can be observed
clinically as bilateral gynecomastia and precocious
puberty, while sporadic cases usually present with
non-tender testicular mass in adolescence. In general,
PJS tumors are bilateral and may be multifocal, while
only 20% of sporadic cases affect both testicles [3, 4].
By and large LCCSC tumors are benign, especially
if they are small and bilateral. Malignant behavior can
be observed in 17% of cases, mainly in lesions[4 cm
or in patients over the age of 20 [4]. Preoperative
work-up should include evaluation of retroperitoneal
Fig. 2 Microscopic features of the tumor a Testicular tumor
composed of trabecles, small tubules and cords of polygonal
mildly pleomorphic cells with abundant eosinophilic cytoplasm
embedded in myxoid stroma with scattered granulocytes.
Additionally, prominent area of ossification is visible. b Low
(2%) proliferative index of tumor cells with Ki-67 antibody.
c Strong cytoplasmic immunoreactivity of alpha inhibin in
tumor cells (shown). The tumor had also strong immunoreac-
tivity for S-100 protein
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lymph nodes, bones, liver and lungs as these are the
most common sites of cancer metastases. On ultra-
sound imaging LCCSCT are usually round, regular,
and hyperechoic with acoustic shadow. Doppler
ultrasound shows increased blood flow in the adjacent
area. Distinctive ultrasound picture helps making
preliminary diagnosis, but it must be remembered
that intratumor hyperechoic elements may also be
present in seminomas, carcinomas embrionale, mature
teratomas as well as in benign lesions caused by post-
traumatic or post-infectious inflammation.
In comparison with traditional treatment of testic-
ular tumors by means of radical inguinal orchidec-
tomy, in case of LCCSCT partial orchidectomy/
tumorectomy seems to be more beneficial surgical
approach [1]. Nevertheless, testicle-sparing surgery is
rational only if several conditions are fulfilled. To start
with, benign character of the tumor must be confirmed
by intraoperative frozen section analysis. Secondly, the
tumor has to be located far from the rete testis and be
smaller than 20–25 mm in order to have enough viable
testicular tissue left. Finally, preoperative testicular
function has to be normal as documented by testoster-
one level [2]. More to the point, after this kind of
surgery, close follow-up must be implemented and it is
usually done by testicular ultrasound imaging [1].
In cases of LCCSCTs that present with additional
abnormalities suggestive of genetic syndromes such as
heart myxoma in Carney complex, or melanin spots
and/or hamartomatous polyps in PJS detection of the
testicular tumor may help to diagnose these entities
and hence enable starting their adequate treatment and
further lifelong oncological surveillance. The reported
patient is a case in point. He does not meet the
generally acknowledged clinical criteria for PJS
diagnosis [7] since he had no signs of GI disease, or
positive family history of PJS in a close relative(s).
Also clinical manifestation of LCCSCT was atypical,
with no endocrinological disturbances and relatively
late age at onset. Nevertheless, STK1 mutational
screening allowed for molecular confirmation of the
disease pointing out the importance of molecular
testing in LCCSCT patients.
Conclusions
Due to a low malignant potential of LCCSCT, it may be
very efficiently treated by testicle-sparing method,
especially in cases of bilateral tumor. Characteristic
phenotypic features of the patients with genetic dys-
plastic syndromes that may coincide with LCCSCT and
typical appearance of the tumor on ultrasound facilitate
its diagnosing prior to surgery and hence reduce the
invasiveness of the treatment. Conversely, LCCSCT
diagnosis enables identification of the underlying
genetic syndrome that may predispose to increased risk
of other neoplasia.
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